Federation Des Caisses Desjardins Du Quebec Windtree Therapeutics Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 14, 2024	SELL	$0.14 - $6.9 $7,000 - $345,000	-50,000 Closed	0 $0
Q4 2022 Aug 14, 2024	BUY	$0.16 - $281.7 $6,400 - $11.3 Million	40,000 Added 400.0%	50,000 $8.5 Million
Q3 2022 Aug 14, 2024	BUY	$0.3 - $306.0 $2,400 - $2.45 Million	8,000 Added 400.0%	10,000 $3 Million
Q1 2022 Aug 14, 2024	BUY	$0.94 - $1.6 $1,880 - $3,200	2,000 New	2,000 $2.28 Million
Q4 2021 Aug 30, 2024	BUY	$1.4 - $2.31 $1,680 - $2,772	1,200 New	1,200 $1.93 Million
Q3 2020 Aug 30, 2024	SELL	$5.5 - $9.9 $5 - $9	-1 Closed	0 $0
Q2 2020 Aug 30, 2024	BUY	$3.3 - $9.96 $3 - $9	1 New	1 $7,000

Others Institutions Holding WINT

# of Institutions

Shares Held

4.09K

Call Options Held

Put Options Held

View Full List

About WINDTREE THERAPEUTICS INC

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $22.1M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

More about WINT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account